Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

View:
Post by capebretongirl on May 14, 2021 10:26am

Last Day

Before the Q1 report which we all know will show $$.  Question is if the sp will react at all to those earnings. Covid revenue will be with us for longer than previously anticipated and with the Ichor/Rexall and airline affiliations we are actually looking good security wise. Hopefully Tripp will have some positive news on Aristotle's reception as that is the medium term longstay here.  This sp has not reacted in a normal way to recent good news and its difficult to understand why - hopefully $3.5 + million reported will change that as Q2,Q3 should be robust as well, hopefully with a boost from Aristotle sales by then.  Fingers crossed and please keep us out of the $.50s as we need some help here........
Comment by Mermer2328 on May 14, 2021 11:00am
with all due respect CBG,this is not difficult to understand at all. Tripp has lost the confidence of most investors. One can only mislead people for so long! I wont make a list because my time is valuable, but You know exactly what has happened here. Cmon.... 2oyrs in the making of a blood test for 10 cancers with high sensitivity and specificity and this is how You unveil the "holy grail ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities